Komipharm International Co (XKRX:041960) Beneish M-Score : -1.91 (As of Apr. 10, 2025)

View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Komipharm International Co's Beneish M-Score or its related term are showing as below:

XKRX:041960' s Beneish M-Score Range Over the Past 10 Years
Min: -3.67 Med: -2.61 Max: -1.91
Current: -1.91

During the past 13 years, the highest Beneish M-Score of Komipharm International Co was -1.91. The lowest was -3.67. And the median was -2.61.

Komipharm International Co Beneish M-Score Historical Data

The historical data trend for Komipharm International Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Beneish M-Score Chart

Komipharm International Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beneish M-Score

Get a 7-Day Free Trial

-2.60

-2.62

-2.75

-2.13

-1.91

Komipharm International Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beneish M-Score	Get a 7-Day Free Trial															-2.13	-1.97	-1.83	-1.78	-1.91

Competitive Comparison of Komipharm International Co's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Komipharm International Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Komipharm International Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Komipharm International Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Komipharm International Co's Beneish M-Score falls into.

Save Embed

;

Save Embed

;

Komipharm International Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Komipharm International Co for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.8839

0.528 * 0.8016

0.404 * 1.5661

0.892 * 1.3783

0.115 * 0.9892

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.8087

4.679 * 0.034751

0.327 * 0.9408

-1.91

This Year (Dec24) TTM:

Last Year (Dec23) TTM:

Total Receivables was ₩21,808 Mil.
Revenue was 15734.079 + 10989.727 + 19153.486 + 12901.257 = ₩58,779 Mil.
Gross Profit was 4342.95 + 3852.866 + 8551.381 + 5016.833 = ₩21,764 Mil.
Total Current Assets was ₩59,935 Mil.
Total Assets was ₩122,767 Mil.
Property, Plant and Equipment(Net PPE) was ₩55,784 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,100 Mil.
Selling, General, & Admin. Expense(SGA) was ₩5,211 Mil.
Total Current Liabilities was ₩46,233 Mil.
Long-Term Debt & Capital Lease Obligation was ₩9,106 Mil.
Net Income was 761.449 + 6492.291 + 5091.378 + 768.15 = ₩13,113 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was 3089.602 + 1927.879 + 1840.296 + 1989.212 = ₩8,847 Mil.

Total Receivables was ₩17,901 Mil.
Revenue was 11486.169 + 7837.549 + 13390.537 + 9932.78 = ₩42,647 Mil.
Gross Profit was 2014.915 + 2212.703 + 4754.376 + 3676.173 = ₩12,658 Mil.
Total Current Assets was ₩50,012 Mil.
Total Assets was ₩118,598 Mil.
Property, Plant and Equipment(Net PPE) was ₩64,239 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,529 Mil.
Selling, General, & Admin. Expense(SGA) was ₩4,675 Mil.
Total Current Liabilities was ₩52,228 Mil.
Long-Term Debt & Capital Lease Obligation was ₩4,593 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(21808.454 / 58778.549)	/	(17901.198 / 42647.035)
	=	0.371027	/	0.419752
	=	0.8839

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(12658.167 / 42647.035)	/	(21764.03 / 58778.549)
	=	0.296812	/	0.370272
	=	0.8016

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (59935.148 + 55784.425) / 122766.616)	/	(1 - (50011.513 + 64239.222) / 118597.807)
	=	0.057402	/	0.036654
	=	1.5661

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	58778.549	/	42647.035
	=	1.3783

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(3529.256 / (3529.256 + 64239.222))	/	(3100.22 / (3100.22 + 55784.425))
	=	0.052078	/	0.052649
	=	0.9892

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(5211.191 / 58778.549)	/	(4675.118 / 42647.035)
	=	0.088658	/	0.109624
	=	0.8087

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((9105.701 + 46233.131) / 122766.616)	/	((4593.472 + 52228.262) / 118597.807)
	=	0.450764	/	0.479113
	=	0.9408

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(13113.268 - 0	-	8846.989)	/	122766.616
	=	0.034751

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Komipharm International Co has a M-score of -1.91 suggests that the company is unlikely to be a manipulator.

Komipharm International Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Komipharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Beneish M-Score

Traded in Other Exchanges

N/A

Address

1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450

Website

http://www.komilab.co.kr

Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines